Systemic Anti-Inflammatory Effects Patients with chronic inflammation, autoimmune conditions, or systemic pain syndromes have shown interest in the potential anti-inflammatory properties of both peptides Clinical Perspective: While patient motivations are valid, it is essential that expectations are calibrated to current evidence
Expected timeline: Week 1-4: Inflammation reduction, potential nerve symptom improvement Week 4-8: Progressive healing, reduced radicular symptoms Week 8-12: Structural improvements developing, continued symptom reduction Week 12-16: Consolidation of gains, assessment for continued protocol Important notes: Disc herniations vary enormously in severity
10.1007/s00018-020-03454-6 47 FardM.Akhavan-TavakoliM.KhanjaniS.ZareS.EdalatkhahH.ArastehS.et al (2018)
OPSS warning BPC-157 Human Clinical Trials Status 2026
Per-Batch HPLC + Copper Content Verification Because GHK-Cu activity depends on intact copper coordination, every lot is screened both by HPLC for peptide purity and by ICP-based analysis for copper content
BPC 157: Speed Up Healing And Enhance Your Vitality With The Miracle Peptide : Green, Neil
